Yanjie Liu, Meiyan Li, Huamei Zhang, Zhe Yin, Xiaoli Wang
{"title":"狼疮性肾炎患者血清中可溶性清道夫受体 CD163 的临床意义。","authors":"Yanjie Liu, Meiyan Li, Huamei Zhang, Zhe Yin, Xiaoli Wang","doi":"10.1177/09612033241276033","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The soluble CD163 (sCD163) was elevated in systemic lupus erythematosus (SLE) patients.</p><p><strong>Purpose: </strong>To study whether serum sCD163 could be used to predict the occurrence and prognosis of lupus nephritis (LN).</p><p><strong>Research design: </strong>The recruited patients were classified into different groups according to standard identification criteria.</p><p><strong>Study sample: </strong>The patients with LN.</p><p><strong>Data collection and analysis: </strong>11 indices were analyzed and compared in SLE and LN patients. Furthermore, the level of serum sCD163 was detected using an enzyme-linked immunosorbent assay. Meanwhile, the receiver operating characteristic analysis was performed to evaluate the prediction effect of sCD163. Additionally, spearman correlation analysis of serum sCD163 with indices was conducted.</p><p><strong>Results: </strong>There were six positive indices and one negative risk factor correlated to LN. sCD163 was elevated in LN patients and could be used to diagnose LN. Importantly, sCD163 was increased in LN patients with a heavy SLE disease activity index. Finally, it was revealed that the level of sCD163 was higher in the LN patients with no response than that with complete or partial response, which also could predict the prognosis of LN.</p><p><strong>Conclusions: </strong>Serum sCD163 was elevated in LN patients than in SLE patients, which could be used to predict the occurrence and prognosis of LN.</p>","PeriodicalId":18044,"journal":{"name":"Lupus","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical significance of serum soluble scavenger receptor CD163 in patients with lupus nephritis.\",\"authors\":\"Yanjie Liu, Meiyan Li, Huamei Zhang, Zhe Yin, Xiaoli Wang\",\"doi\":\"10.1177/09612033241276033\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The soluble CD163 (sCD163) was elevated in systemic lupus erythematosus (SLE) patients.</p><p><strong>Purpose: </strong>To study whether serum sCD163 could be used to predict the occurrence and prognosis of lupus nephritis (LN).</p><p><strong>Research design: </strong>The recruited patients were classified into different groups according to standard identification criteria.</p><p><strong>Study sample: </strong>The patients with LN.</p><p><strong>Data collection and analysis: </strong>11 indices were analyzed and compared in SLE and LN patients. Furthermore, the level of serum sCD163 was detected using an enzyme-linked immunosorbent assay. Meanwhile, the receiver operating characteristic analysis was performed to evaluate the prediction effect of sCD163. Additionally, spearman correlation analysis of serum sCD163 with indices was conducted.</p><p><strong>Results: </strong>There were six positive indices and one negative risk factor correlated to LN. sCD163 was elevated in LN patients and could be used to diagnose LN. Importantly, sCD163 was increased in LN patients with a heavy SLE disease activity index. Finally, it was revealed that the level of sCD163 was higher in the LN patients with no response than that with complete or partial response, which also could predict the prognosis of LN.</p><p><strong>Conclusions: </strong>Serum sCD163 was elevated in LN patients than in SLE patients, which could be used to predict the occurrence and prognosis of LN.</p>\",\"PeriodicalId\":18044,\"journal\":{\"name\":\"Lupus\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lupus\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/09612033241276033\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/8/22 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"RHEUMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lupus","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/09612033241276033","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/22 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
Clinical significance of serum soluble scavenger receptor CD163 in patients with lupus nephritis.
Background: The soluble CD163 (sCD163) was elevated in systemic lupus erythematosus (SLE) patients.
Purpose: To study whether serum sCD163 could be used to predict the occurrence and prognosis of lupus nephritis (LN).
Research design: The recruited patients were classified into different groups according to standard identification criteria.
Study sample: The patients with LN.
Data collection and analysis: 11 indices were analyzed and compared in SLE and LN patients. Furthermore, the level of serum sCD163 was detected using an enzyme-linked immunosorbent assay. Meanwhile, the receiver operating characteristic analysis was performed to evaluate the prediction effect of sCD163. Additionally, spearman correlation analysis of serum sCD163 with indices was conducted.
Results: There were six positive indices and one negative risk factor correlated to LN. sCD163 was elevated in LN patients and could be used to diagnose LN. Importantly, sCD163 was increased in LN patients with a heavy SLE disease activity index. Finally, it was revealed that the level of sCD163 was higher in the LN patients with no response than that with complete or partial response, which also could predict the prognosis of LN.
Conclusions: Serum sCD163 was elevated in LN patients than in SLE patients, which could be used to predict the occurrence and prognosis of LN.
期刊介绍：
The only fully peer reviewed international journal devoted exclusively to lupus (and related disease) research. Lupus includes the most promising new clinical and laboratory-based studies from leading specialists in all lupus-related disciplines. Invaluable reading, with extended coverage, lupus-related disciplines include: Rheumatology, Dermatology, Immunology, Obstetrics, Psychiatry and Cardiovascular Research…
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
